1. Home
  2. EVAX vs ZDAI Comparison

EVAX vs ZDAI Comparison

Compare EVAX & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • ZDAI
  • Stock Information
  • Founded
  • EVAX 2008
  • ZDAI 2022
  • Country
  • EVAX Denmark
  • ZDAI Hong Kong
  • Employees
  • EVAX N/A
  • ZDAI N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • ZDAI General Bldg Contractors - Nonresidential Bldgs
  • Sector
  • EVAX Health Care
  • ZDAI Consumer Discretionary
  • Exchange
  • EVAX Nasdaq
  • ZDAI Nasdaq
  • Market Cap
  • EVAX 17.8M
  • ZDAI 14.8M
  • IPO Year
  • EVAX 2021
  • ZDAI 2024
  • Fundamental
  • Price
  • EVAX $6.70
  • ZDAI $0.49
  • Analyst Decision
  • EVAX Strong Buy
  • ZDAI
  • Analyst Count
  • EVAX 2
  • ZDAI 0
  • Target Price
  • EVAX $13.50
  • ZDAI N/A
  • AVG Volume (30 Days)
  • EVAX 894.4K
  • ZDAI 92.7K
  • Earning Date
  • EVAX 11-07-2025
  • ZDAI 11-11-2025
  • Dividend Yield
  • EVAX N/A
  • ZDAI N/A
  • EPS Growth
  • EVAX N/A
  • ZDAI N/A
  • EPS
  • EVAX N/A
  • ZDAI N/A
  • Revenue
  • EVAX $3,176,000.00
  • ZDAI $19,275,673.00
  • Revenue This Year
  • EVAX $129.34
  • ZDAI N/A
  • Revenue Next Year
  • EVAX N/A
  • ZDAI N/A
  • P/E Ratio
  • EVAX N/A
  • ZDAI N/A
  • Revenue Growth
  • EVAX 1042.45
  • ZDAI 43.16
  • 52 Week Low
  • EVAX $1.20
  • ZDAI $0.37
  • 52 Week High
  • EVAX $15.50
  • ZDAI $107.36
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 54.71
  • ZDAI 37.51
  • Support Level
  • EVAX $5.29
  • ZDAI $0.48
  • Resistance Level
  • EVAX $6.82
  • ZDAI $0.53
  • Average True Range (ATR)
  • EVAX 1.23
  • ZDAI 0.04
  • MACD
  • EVAX -0.22
  • ZDAI -0.01
  • Stochastic Oscillator
  • EVAX 20.53
  • ZDAI 7.66

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

About ZDAI Primega Group Holdings Limited Ordinary Shares

DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.

Share on Social Networks: